Synthetic Biologics stock hits 52-week low at $1.08

Published 13/03/2025, 20:08
Synthetic Biologics stock hits 52-week low at $1.08

Synthetic Biologics Inc (TOVX) stock has reached a 52-week low, trading at $1.08, with a market capitalization of just $3.37 million. According to InvestingPro analysis, the company’s overall financial health score stands at 1.6, indicating significant weakness. This price level reflects a significant downturn for the company, which has experienced an 87.8% decline over the past year. While the company maintains a healthy current ratio of 2.15 and holds more cash than debt, InvestingPro analysis reveals concerning trends in cash burn rate and profit margins. Investors have been closely monitoring the stock as it struggles to regain momentum amidst a challenging period for the biotech industry. The 52-week low serves as a critical indicator of the company’s current market position and investor sentiment, as it navigates through a phase of uncertainty and seeks to implement strategies for recovery and growth. For deeper insights into TOVX’s financial health and growth prospects, investors can access 10+ additional ProTips and comprehensive analysis through InvestingPro’s detailed research reports.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.